Assessing bone gain in maxilla atrophy using collagen membranes

Assessment of Bone Gain Following Composite Graft Rehabilitation of Horizontal Maxilla Atrophy With Sausage Technique Utilizing (Pericardial) Collagen Membrane Versus Periosteal Membrane Harvested From the Iliac Crest A Randomized Clinical Trial

Not applicable Interventional Cairo University · NCT06831214

This study is testing if using special collagen membranes can help patients with bone loss in their upper jaw gain enough bone for dental implants.

Quick facts

PhaseNot applicable
Study typeInterventional
Enrollment22 (estimated)
Ages18 Years to 60 Years
SexAll
SponsorCairo University Academic / other
Locations1 site (Cairo)
Trial IDNCT06831214 on ClinicalTrials.gov

What this trial studies

This study evaluates the effectiveness of a composite graft rehabilitation technique for patients with horizontal maxilla atrophy, comparing the use of pericardial collagen membranes to periosteal membranes harvested from the iliac crest. The sausage technique is employed to stabilize the graft and promote bone gain over a period of six months. The research aims to address the challenges posed by severe horizontal bone defects that complicate dental implant placement. By measuring the amount of bone gain achieved, the study seeks to provide insights into optimal grafting strategies for improved dental outcomes.

Who should consider this trial

Good fit: Ideal candidates include adults aged 18-60 with unilateral or bilateral horizontal maxilla atrophy and no prior interventions on the donor or host sites.

Not a fit: Patients with syndromic conditions or systemic diseases affecting bone metabolism may not benefit from this study.

Why it matters

Potential benefit: If successful, this study could enhance the success rates of dental implants in patients with significant maxillary bone loss.

How similar studies have performed: Other studies have shown promising results with similar grafting techniques, indicating potential for success in this approach.

Eligibility criteria

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age range (18-60 years)
* Patients with unilateral or bilateral horizontal atrophy in maxilla with minimum 1 quadrant.
* No intervention done previously on the donor and host sides.
* No sex predilection

Exclusion Criteria:

* Syndromic patients.
* bone metabolism \& systemic diseases.

Where this trial is running

Cairo

Study contacts

How to participate

  1. Review the eligibility criteria above with your treating physician.
  2. Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
  3. Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions Maxilla Atrophycollagen membranePeriosteal membrane
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.